Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly

Neurobiology of Aging

Volumn 35, Issue 1, 2014, Pages 64-71

  Glodzik, Lidia ^a   Rusinek, Henry ^a   Pirraglia, Elizabeth ^a   McHugh, Pauline ^a   Tsui, Wai ^a   Williams, Schantel ^a   Cummings, Megan ^a   Li, Yi ^a   Rich, Kenneth ^a   Randall, Catherine ^a   Mosconi, Lisa ^a   Osorio, Ricardo ^a   Murray, John ^a   Zetterberg, Henrik ^b,c   Blennow, Kaj ^b   de Leon, Mony ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cognition; CSF biomarkers; Low blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; BIOLOGICAL MARKER; TAU PROTEIN; THREONINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISODIC MEMORY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL ATROPHY; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LONGITUDINAL STUDY; LUMBAR PUNCTURE; MALE; MEAN ARTERIAL PRESSURE; MEDICAL ASSESSMENT; MEMORY DISORDER; NEUROLOGIC EXAMINATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

COGNITION; CSF BIOMARKERS; LOW BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; ATROPHY; BIOLOGICAL MARKERS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; FEMALE; HIPPOCAMPUS; HUMANS; HYPERTENSION; MALE; MEMORY DISORDERS; MEMORY, EPISODIC; MIDDLE AGED; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX; TAU PROTEINS;

EID: 84885175046     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.06.011     Document Type: Article

References (56)

1. Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(suppl 1):S11-S61. American Diabetes Association.
2. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol. 1999, 56:673-680.
3. Appelman A.P., van der Graaf Y., Vincken K.L., Tiehuis A.M., Mali W.P., Geerlings M.I., Smeeth Liam Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study. J.Cereb. Blood Flow Metab. 2008, 28:633-639. SMART Study Group.
4. Ball M.J., Hachinski V., Fox A., Kirshen A.J., Fisman M., Blume W., Kral V.A., Fox H. Anew definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985, 1:14-16.
5. Bech P., Kastrup M., Rafaelsen O.J. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr. Scand. Suppl. 1986, 326:1-37.
6. Birns J., Kalra L. Cognitive function and hypertension. J.Hum. Hypertens. 2009, 23:86-96.
7. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 1995, 26:231-245.
8. Brickman A.M., Reitz C., Luchsinger J.A., Manly J.J., Schupf N., Muraskin J., DeCarli C., Brown T.R., Mayeux R. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch. Neurol. 2010, 67:564-569.
9. Chobonian A., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Matterson B.J., Oparil S., Wright J.T., Rocella E.J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003, 289:2560-2572.
10. Crook T., Gilbert J.G., Ferris S.H. Operationalizing memory impairment in elderly persons: the Guild memory test. Psychol. Rep. 1980, 47:1315-1318.
11. De Santi S., Pirraglia E., Barr W.B., Babb J., Williams S., Rogers K., Glodzik L., Brys M., Mosconi L., Reisberg B., Ferris S., de Leon M.J. Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology 2008, 22:469-484.
12. den Heijer T., Launer L.J., Prins N.D., van Dijk E.J., Vermeer S.E., Hofman A., Koudstaal P.J., Breteler M.M. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005, 64:263-267.
13. den Heijer T., Skoog I., Oudkerk M., de Leeuw F.E., de Groot J.C., Hofman A., Breteler M.M. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol. Aging 2003, 24:307-313.
14. Fang H., Zhang L.F., Meng F.T., Zhou J.N. Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci. Lett. 2010, 474:173-177.
15. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
16. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
17. Frank L.M., Brown E.N., Stanley G.B. Hippocampal and cortical place cell plasticity: implications for episodic memory. Hippocampus 2006, 16:775-784.
18. Gilbert J.G. Guild Memory Test Manual 1970, UNICO National Mental Health Research Center, Newark, NJ.
19. Glodzik L., De Santi S., Tsui W.H., Mosconi L., Zinkowski R., Pirraglia E., Wang H., Li Y., Rich K.E., Zetterberg H., Blennow K., Mehta P., de Leon M.J. Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol. Aging 2011, 32:2131-2141.
20. Glodzik-Sobanska L., Rusinek H., Mosconi L., Li Y., Zhan J., De Santi S., Convit A., Rich K.E., Brys M., de Leon M.J. The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease. Neuroimaging Clin. N. Am. 2005, 15:803-826.
21. Guo Z., Viitanen M., Fratiglioni L., Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996, 312:805-808.
22. Hajjar I., Kotchen J.M., Kotchen T.A. Hypertension: trends in prevalence, incidence, and control. Annu. Rev. Public Health 2006, 27:465-490.
23. Jack C.R., Vemuri P., Viste H.J., Weigand S.D., Aisen P.S., Trojanowski J.Q., Shaw L.M., Bernstein M.A., Petersen R.C., Weiner M.W., Knopman D.S. Evidence for ordering of Alzheimer disease biomarkers. Arch. Neurol. 2011, 68:1526-1535. for the Alzheimer's Diasease Neuroimaging Initiative.
24. Kennelly S.A., Lawlor B., Kenny R.A. Blood pressure and the risk for dementia-a double edged sword. Aging Res. Rev. 2009, 8:61-70.
25. Kester M.I., van der Flier W.M., Mandic G., Blankenstein M.A., Scheltens P., Muller M. Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's disease. J.Alzheimers Dis. 2010, 20:1083-1090.
26. Kluger A., Ferris S.H., Golomb J., Mittelman M.S., Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. J.Geriatr. Psychiatry Neurol. 1999, 12:168-179.
27. Koike M.A., Green K.N., Blurton-Jones M., LaFerla F.M. Oligemic hypoperfusion differentially affects tau and amyloid-beta. Am. J. Pathol. 2010, 177:300-310.
28. Lee P.H., Hwang E.M., Hong H.S., Boo J.H., Mook-Jung I., Huh K. Effect of ischemic neuronal insults on amyloid precursor protein processing. Neurochem. Res. 2006, 31:821-827.
29. Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension: a new target for treatment?. Circulation 2001, 104:735-740.
30. Li J., Wang Y.-J., Zhang M., Fang C.-Q., Zhou H.-D. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. Life Sci. 2011, 89:86-92.
31. Lin Y.T., Cheng J.T., Yao Y.C., Juo L.I., Lo Y.K., Lin C.H., Ger L.P., Lu P.J. Increased total tau but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer's disease. J.Alzheimers Dis. 2009, 18:907-918.
32. Lucas S.J.E., Tzeng Y.C., Galvin S.D., Thomas K.N., Ogoh S., Ainslie P.N. Influence of changes in blood pressure on cerebral perfusion and oxygenation. Hypertension 2010, 55:698-705.
33. Main B.F., Jones P.J., MacGillivray R.T., Banfield D.K. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers. J.Lipid Res. 1991, 32:183-187.
34. McGuinness B., Todd S., Passmore P., Bullock R. Blood pressure loweringin patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst. Rev 2009, Art. No. CD004034.
35. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
36. Muller M., Jochemsen H.M., Visseren F.L.J., Grool A.M., Launer L.J., van der Graaf Y., Geerlings M.I. Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study. J.Intern. Med 2013, The SMART-study group. http://dx.doi.org/10.1111/joim.12069.
37. Muller M., van der Graaf Y., Visseren F.L., Mali W.P.T., Geerlings M.I. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann. Neurol. 2012, 71:825-833. SMART Study Group.
38. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adult Treatment panel III). Final Report. Circulation 2002, 106:3143. NIH Publication No. 02-5125, US Department of Health and Human Services NIH/NHLBI.
39. Qiu C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005, 4:487-499.
40. Reisberg B., Sclan S.G., Franssen E.H., de Leon M.J., Kluger A., Torossian C.L., Shulman E., Steinberg G., Monteiro I., McRae T., Boksay I., Mackell J.A., Ferris S.H. Clinical stages of normal aging and Alzheimer's disease: the GDS staging system. Neurosci. Res. Commun. 1993, 13(suppl 1):551-554.
41. Rorden C., Brett M. Stereotaxic display of brain lesions. Behav. Neurol. 2000, 12:191-200.
42. Ruitenberg A., Skoog I., Ott A., Aevarsson O., Witteman J.C.M., Lernfelt B., vanHarskamp F., Hofman A., Breteler M.M.B. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 study. Dementia Geriatr. Cogn. Disord. 2001, 12:33-39.
43. Safar M.E., Nilsson P.M., Blacher J., Mimran A. Pulse pressure, arterial stiffness, and end-organ damage. Curr. Hypertens. Rep. 2012, 14:339-344.
44. Schneider J.A. High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer's disease. J.Am. Geriatr. Soc. 2009, 57:2146-2147.
45. Sparks D.L., Scheff S.W., Liu H., Landers T.M., Coyne C.M., Hunsaker J.C.I. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J.Neurol. Sci. 1995, 131:162-169.
46. Steiner L.A., Andrews P.J.D. Monitoring the injured brain: ICP and CBF. Br. J. Anaesth. 2006, 97:26-38.
47. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L.E., Song W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U.S.A 2006, 103:18727-18732.
48. Tzeng Y.C., Willie C.K., Atkinson G., Lucas S.J.E., Wong A., Ainslie P.N. Cerebrovascular regulation during transient hypotension and hypertension in humans. Hypertension 2010, 56:268-273.
49. van Beek A.H., Claassen J.A., Rikkert M.G., Jansen R.W. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J.Cereb. Blood Flow Metab. 2008, 28:1071-1085.
50. Vanmechelen E., Vanderstichele H., Davidsson P., Van Kerschaver E., Van Der Perre B., Sjogren M., Andreasen N., Blennow K. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci. Lett. 2000, 285:49-52.
51. Verghese J., Lipton R.B., Hall C.B., Kuslansky G., Katz M.J. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003, 61:1667-1672.
52. Vidoni E.D., Townley R.A., Honea R.A., Burns J.M. Alzheimer disease biomarkers are associated with body mass index. Neurology 2011, 77:1913-1920. for the Alzheimer's Disease Neuroimaging Initiative.
53. Zarow C., Vinters H.V., Ellis W.G., Weiner M.W., Mungas D., White L., Chui H.C. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann. Neurol. 2005, 57:896-903.
54. Zazulia A.R. Regulation of cerebral blood flow in untreated mild-to-moderate hypertension. Am. J. Hypertens. 2009, 22:344.
55. Zetterberg H., Mortberg E., Song L., Chang L., Provuncher G.K., Patel P.P., Ferrell E., Fourrnier D.R., Kan C.W., Campbell T.G., Meyer R., Rivnak A.J., Pink B.A., Minnehan K.A., Piech T., Rissin D.M., Duffy D.C., Rubertsson S., Wilson D.H., Blennow K. Hypoxia due to cardiac arrest induces a time-dependent increasein serum amyloid beta levels in humans. PLoS One 2011, 6:e28263. 1-6.
56. Zola-Morgan S., Squire L.R., Rempel N.L., Clower R.P., Amaral D.G. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J.Neurosci. 1992, 12:2582-2596.